News
The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...
French IT major Capgemini will acquire Indian-origin BPO firm WNS in a $3.3 billion cash deal. This and more in todays ETtech ...
Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment ...
Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced ...
Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer ...
See the latest ADMA Biologics Inc stock price (ADMA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...
In March 2024, Formosa Pharmaceuticals and AimMax Therapeutics received FDA approval for clobetasol propionate ophthalmic suspension 0.05% (APP13007) to treat postoperative inflammation and pain after ...
Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...
The annual sepsis update distilled a year’s worth of high-impact evidence into practice-ready guidance for busy hospitalists.
AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...
Qiming Venture Partners has been a long-standing investor in Unisound, first participating in the company’s Series A funding round in 2013. Over the past decade, Qiming has continued to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results